Drug Discovery of Biologics Primer 201

Drug Discovery of Biologics Primer 201 builds upon the foundational knowledge of Drug Discovery of Biologics Primer 101, focusing on systematic insights into therapeutic antibody discovery. This course begins with the significance of antibody screening and structure-based affinity maturation, emphasizing antibody Chemistry, Manufacturing, and Controls (CMC) liabilities. Covering four therapeutic antibody classes, including immune checkpoint inhibitors, this class showcases the factors that influence early drug candidate selection. The data and transition criteria essential for advancing candidate drugs from the discovery phase to preclinical development are also covered. Enroll today to deepen your therapeutic antibody drug discovery knowledge!

Section 1: Drug Discovery Workflow

Explore the critical stages of drug development, from identifying and validating drug targets to selecting and optimizing lead candidates. Gain insights into preclinical and clinical development processes in the pharmaceutical industry.

Section 2: Affinity Maturation and CMC Liabilities

Dive into structure-based affinity maturation techniques, including targeted diversification, chain shuffling, and formulation. Understand the critical aspects of Chemistry, Manufacturing, and Controls (CMC) liabilities, covering issues like aggregation, solubility, immunogenicity, and glycation in drug development.

Section 3: Early Drug Candidate Selection

Explore the influence of drug size and complexity on target interactions, criteria in the drug discovery process, and the role of in silico, in vitro, and in vivo models. Delve into the functions and structures of human immunoglobulins, focusing on Fc and Fab regions.

Section 4: Antibody Diversity

Discover various therapeutic antibody classes, including canonical blocking antibodies, antibody-drug conjugates, antibody-like molecules, and immune response reactivators. Additionally, explore the essential concepts of cell banking, encompassing master cell banks and working cell banks.

Section 5: Discovery to Development Criteria

Explore the in vitro quantitative activity profile, covering in vitro ADME studies, pharmacokinetic studies, and pharmacokinetic biomarkers. Dive into in vivo efficacy studies, safety/toxicity studies, and learn how to estimate clinical doses and evaluate candidate transition criteria.

Five Takeaways


  1. Master the drug discovery workflow and align specific goals for successful development.
  2. Analyze the early drug candidate selection criteria and consider therapeutic antibody properties in the selection process.
  3. Utilize in silicon, in vitro, and in vivo models to investigate functional pharmacological activity.
  4. Demonstrate proficiency in the drug discovery considerations needed for the four distinct classes of antibody therapeutics.
  5. Investigate pharmacology data and transition criteria to determine which drug candidates are progressing into preclinical development.

Ready to get started?

Get in touch or enroll now


  • Closed Captioning in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
  • Transcripts in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
  • Course materials
  • Real-time tracking
  • Progress reporting
  • Accessibility features
  • Corporate account upgrades
  • LinkedIn certificate attachment
  • Verified certificates


  • How long do I have to complete an on-demand course?  You have one year from the date of purchase to complete the course. During that year, you may watch the class an unlimited number of times.
  • What happens if I don’t complete the course in one year?  There are no time extensions. If you want to complete the course, you must purchase it again.
  • How long are the on-demand classes?  Our longest course has a running time of 90 minutes. However, most have a running time of 45 minutes.  The running time is listed for each class on its registration page. The assessment at the end of each course takes between 10-20 minutes to complete.
  • Are there any downloadable class materials? No. All course slides and transcripts remain on your Biotech Primer dashboard, but they are always available for review.
  • What is the format of the on-demand classes?  The online class begins with the class objectives and the course itself and ends with a summary of what you learned. The course is a series of images and text accompanied by a professional voice-over and subtitles. Subtitles are available in 9 languages. The course ends with a quiz to assess your understanding.
  • Can I repeat the course?  You can repeat the course as often as you like within your one-year access.
  • How many times can I take the course quiz?  You have three chances to pass the quiz. A passing score is 75% or higher. You must pass the quiz to receive the class certificate. Your quiz score will be shown on your class certificate.
  • May I share a course I purchased with others?  Each course is to be taken by one individual. If you want to learn as a group, please contact us at training@biotechprimer.com for group pricing.
Powered By MemberPress WooCommerce Plus Integration